Rajesh Chopra

15.4k citations
171 papers · 8.9k indexed · 5 hit papers · h-index 48
Topics
Multiple Myeloma Research and Treatments (37 papers)Protein Degradation and Inhibitors (35 papers)Lymphoma Diagnosis and Treatment (18 papers)

In The Last Decade

Rajesh Chopra

165 papers receiving 8.7k citations

Hit Papers

Dose intensification with autologous bone-marrow transpla...199320262004201519932012200620132014250500750

Peers

Rajesh Chopra
Comparison fields: 5 of 144
  • Hematology 3.2k
  • Oncology 2.8k
  • Molecular Biology 2.6k
  • Pathology and Forensic Medicine 2.3k
  • Immunology 1.7k
Replace Ofer Shpilberg with:
Ofer Shpilberg Israel
Mitsune Tanimoto Japan
Giorgina Specchia Italy
Yves Béguin Belgium
Yok‐Lam Kwong China
Francesco Di Raimondo Italy
Aaron Polliack Israel
Franco Dammacco Italy
E. William St. Clair United States
Edward A. Stadtmauer United States
Rajesh Chopra relative to Ofer Shpilberg Israel Ofer Shpilberg's profile →
Citations per field
00.5×1.5×
Ofer Shpilberg · 1×
Citations per year

Countries citing papers authored by Rajesh Chopra

Since Specialization
Citations

This map shows the geographic impact of Rajesh Chopra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh Chopra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh Chopra more than expected).

Fields of papers citing papers by Rajesh Chopra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh Chopra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh Chopra. The network helps show where Rajesh Chopra may publish in the future.

Co-authorship network of co-authors of Rajesh Chopra

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh Chopra. A scholar is included among the top collaborators of Rajesh Chopra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh Chopra. Rajesh Chopra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 23
2 1
3 0
4 45
5 1
6 20
7 7
8 74
9 28
10 8
11 4
12
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate T cells by inducing degradation of T cell repressors I karos and A iolos via modulation of the E 3 ubiquitin ligase complex CRL 4 CRBN breakdown →
457
13 58
14 161
15 81
16 45
17 11
18 2
19 34
20 217

About Rajesh Chopra

Rajesh Chopra is a scholar working on Hematology, Genetics and Oncology, having authored 171 papers that have together received 8.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (37 papers), Protein Degradation and Inhibitors (35 papers) and Lymphoma Diagnosis and Treatment (18 papers). The work is most often cited by research in Hematology (3.2k citations), Genetics (1.6k citations) and Pathology and Forensic Medicine (2.3k citations). Rajesh Chopra has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include David C. Linch, A. H. Goldstone, Peter Schäfer, Anita K. Gandhi, William Adler, D. J. Moir, Annabel McMillan, G. Vaughan Hudson, D.A. Winfield and D Milligan. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026